Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Pneumococcal Disease Vaccines
Researchers from University of Munich detail findings in pneumococcal disease vaccines
January 21st, 2009
Scientists discuss in 'Safety and effectiveness against respiratory tract infections for pneumococcal conjugate vaccine co-administered with routine vaccine combinations' new findings in pneumococcal disease. According to recent research from Munich, Germany, "Streptococcus pneumoniae is a major cause of bacterial pneumonia and other respiratory tract infections (RTI) in children. The heptavalent conjugated pneumococcal vaccine (PCV7) is offering a promising strategy against pneumococcal disease in children younger than 2 years." "In this prospective epidemiological study in Germany, children between 2 and 6 months of age received in a 3:1 ratio a routine...
Source: Vaccine Weekly (2009-01-21)
|
